Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech...
Read moreITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX:RAD; NASDAQ: RADX ‘Radiopharm’), a developer...
Read moreMetro Mining (MMI:AU) has announced Reserve and Resource Update Download the PDF here. This post appeared first on investingnews.com
Read moreSilver has lagged behind gold’s record run, causing the gold-silver ratio to stretch near historic extremes. With the gold price...
Read moreBrightstar Resources (BTR:AU) has announced High-grade results incl 16m @ 8g/t Au in Menzies drilling Download the PDF here. This...
Read moreAfter spending most of 2025’s first quarter consolidating at the US$63 per pound level, spot U3O8 prices have been on...
Read moreBrightstar Resources (BTR:AU) has announced Group Resource Update Underpins Future Mining Download the PDF here. This post appeared first on...
Read moreAs the global energy transition accelerates, the mining sector is increasingly navigating a complex landscape of shifting demand, volatile prices...
Read moreInternational Graphite (IG6:AU) has announced Feedback of U.S. Department of Defense Award Funding Download the PDF here. This post appeared...
Read moreGreenvale Energy (GRV:AU) has announced CEO Appointment Download the PDF here. This post appeared first on investingnews.com
Read moreDisclaimer: financemasterynews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.